Cytovia Therapeutics
Develops transformational cancer immunotherapies and addresses several unmet medical needs for cancer prevention.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD821m (Public information from Apr 2022)
Aventura Florida (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$45.0m | Late VC | ||
* | $207m Valuation: $602m | SPAC IPO | |
* | N/A | $20.0m Valuation: $602m | SPAC Private Placement |
| Total Funding | CAD88.6m | ||
Related Content
Recent News about Cytovia Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.